Dow and Evonik have entered into an exclusive technology partnership. Together, they plan to bring a unique method for directly synthesizing propylene glycol (PG) from propylene and hydrogen peroxide to market maturity.
The basis for the method, named HYPROSYN™, has been created over the last few years by a team of over 100 Evonik employees. The key element is a novel catalytic system developed by Evonik researchers which allows for the direct synthesis of PG from propylene and hydrogen peroxide, in a process offering high yield and comparatively low energy consumption.
Some 1.9 million metric tons of propylene glycol were used worldwide in 2018. The molecule is used in the production of polyester resins and as a de-icing agent. It is also an important food additive and serves as a humectant and co-surfactant in many products in the home and personal care market.
“We are very pleased to be cooperating with Dow to bring the HYPROSYN™ process to market maturity. Dow is by far the largest producer of PG worldwide and a world leader in the field of material science. Dow’s technical and market experience will be invaluable in the scale up of our development” says Michael Träxler, the head of Evonik’s Active Oxygens business line.
A pilot plant is to be constructed at the Evonik site in Hanau by the end of 2020, with large-scale technical implementation to follow a few years later. “We believe that the new HYPROSYN™ direct synthesis technology will enable a more competitive route to produce PG with an improved environmental profile, providing us greater flexibility in serving our customers" says Andrew Jones, global business director for Propylene Oxide, Propylene Glycol, Chlor-Alkali and Vinyl at Dow. Dow is the only truly global PG producer with five production facilities located on four continents.
In the traditional process propylene oxide (PO) is converted to PG using water. The HYPROSYN™ technology offers several advantages over that process:
- It is expected to consume significantly less energy while providing a higher yield.
- The HYPROSYN™ process combines all reaction steps in a single reactor, eliminating the need for investment in additional PO capacity. Existing PG plants can be retrofitted with little effort.
- Only hydrogen peroxide and propylene are processed as feedstock, increasing flexibility and lowering total investment cost.
“In addition to potential license revenue, this partnership also demonstrates how we create new areas of application for hydrogen peroxide and positions us as a preferred provider," said Träxler. In recent years, the molecule has become established as an important oxidizing agent for chemical synthesis – not least as a result of the HPPO process for the production of propylene oxide.
“We are pleased to work together with Evonik to bring this sustainable and innovative new technology to market. We believe it is an important development in support of growing demand from our PG customers worldwide” says Jones.
Evonik is one of the world’s largest manufacturers of hydrogen peroxide, one of the two starting materials for the HYPROSYN® process. The company’s 13 production sites distributed throughout the world ensure an optimal supply of hydrogen peroxide (H2O2) with an annual capacity of more than 950,000 metric tons.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world. In fiscal 2018, the enterprise with more than 32,000 employees generated sales of €13.3 billion and an operating profit (adjusted EBITDA) of €2.15 billion from continuing operations.
Evonik’s international activities are organized into six regions. The Asia Pacific North region is headquartered in Shanghai. Sales in Asia Pacific North reached €1.97 billion in 2018. Evonik regards China as one of the driving forces of the global economy and we consequently endeavor to grow our business here. The company now employs over 2,500 employees and has in total of 10 production sites in China.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.